| pubmed-article:11248623 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C0194810 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C1521733 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C0445204 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C1705764 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C1518823 | lld:lifeskim |
| pubmed-article:11248623 | lifeskim:mentions | umls-concept:C2348519 | lld:lifeskim |
| pubmed-article:11248623 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11248623 | pubmed:dateCreated | 2001-3-15 | lld:pubmed |
| pubmed-article:11248623 | pubmed:abstractText | To improve the accuracy of predicting pathologic stage and biochemical recurrence after radical prostatectomy (RP), we sought to determine whether preoperative prostate-specific antigen (PSA) velocity and doubling time predict adverse pathologic features or biochemical recurrence following RP. We also sought to determine if there were racial differences in preoperative PSA velocity and doubling time. | lld:pubmed |
| pubmed-article:11248623 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11248623 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11248623 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11248623 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11248623 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11248623 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11248623 | pubmed:issn | 1527-9995 | lld:pubmed |
| pubmed-article:11248623 | pubmed:author | pubmed-author:DoreyFF | lld:pubmed |
| pubmed-article:11248623 | pubmed:author | pubmed-author:AronsonW JWJ | lld:pubmed |
| pubmed-article:11248623 | pubmed:author | pubmed-author:FreedlandS... | lld:pubmed |
| pubmed-article:11248623 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:11248623 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:11248623 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11248623 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11248623 | pubmed:pagination | 476-80 | lld:pubmed |
| pubmed-article:11248623 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:meshHeading | pubmed-meshheading:11248623... | lld:pubmed |
| pubmed-article:11248623 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11248623 | pubmed:articleTitle | Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy. | lld:pubmed |
| pubmed-article:11248623 | pubmed:affiliation | Department of Urology, UCLA School of Medicine, Los Angeles, California 90095-1738, USA | lld:pubmed |
| pubmed-article:11248623 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11248623 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11248623 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11248623 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11248623 | lld:pubmed |
